欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2255/001
药品名称Optivate 250 IU, Optivate 500 IU and Optivate 1000 IU
活性成分
    • blood coagulation factor VIII human 260.0 µ
剂型Powder for solution for infusion/injection
上市许可持有人RMS transfer from UK/H/4591/001 Bio Products Laboratory Dagger Lane, Elstree, Hertfordshire, WD6 3BX, UK
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 08801/0051 - 0112
    • Malta (MT)
    • Czechia (CZ)
    • Romania (RO)
      Optivate 100 UI/ml pulbere şi solvent pentru soluţie injectabilă
    • Poland (PL)
    • Slovakia (SK)
      Optivate
许可日期2012/06/14
最近更新日期2024/03/04
药物ATC编码
    • B02BD02 coagulation factor VIII
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase